SCHEMBL4276406

SCHEMBL4276406

CCOC(=O)/C=C(\c1ccc(OCC(C)C)c(CC(=O)O)c1)c1ccc(OCCC(C)C)c(OCCC(C)C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
HIF1A Q16665 1/20 0.43
FOS P01100 2/20 0.41
JUN P05412 2/20 0.41
HTT P42858 2/20 0.41
MYC P01106 1/20 0.38
MAX P61244 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
LTB4R Q15722 4/20 0.36
LTB4R2 Q9NPC1 4/20 0.36
MAPT P10636 1/20 0.36
PKM P14618 1/20 0.36
TSHR P16473 1/20 0.36
POLB P06746 1/20 0.36
CASP6 P55212 1/20 0.36
PDE4B Q07343 1/20 0.36
MAPK1 P28482 1/20 0.36
PLA2G2D Q9UNK4 1/20 0.35
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4276411 1.00 ALDH1A1 (0.43) ALDH1A1HIF1AFOSJUNHTT
SCHEMBL4853208 0.80 FOS (0.48) ALDH1A1HIF1AFOSJUNHTT
SCHEMBL4281229 0.76 MAPK1 (0.42) ALDH1A1HIF1AFOSJUNHTT
SCHEMBL4281226 0.76 MAPK1 (0.42) ALDH1A1HIF1AFOSJUNHTT
SCHEMBL4279655 0.74 FOS (0.56) ALDH1A1HIF1AFOSJUNHTT
SCHEMBL4280462 0.74 FOS (0.61) ALDH1A1HIF1AFOSJUNHTT
SCHEMBL4280458 0.74 FOS (0.61) ALDH1A1HIF1AFOSJUNHTT
SCHEMBL4277956 0.71 CYP19A1 (0.44) ALDH1A1FOSJUNHTTSMN1; SMN2
SCHEMBL4280876 0.71 THRA (0.47) ALDH1A1HTTSMN1; SMN2MAPK1THRA
SCHEMBL4276633 0.70 MAPK1 (0.64) ALDH1A1HTTTSHRPOLBCASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118169-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-05-07 US disclosed
US-7314888-B1 Compounds and medicinal use thereof TOYAMA CHEMICAL CO., LTD. (JP) 2008-01-01 US disclosed
EP-1127869-A1 NOVEL COMPOUNDS AND MEDICINAL USE THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2001-08-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118169-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF SP1, AP1G1, AP1M1 ALDH1A1 2031/4885HIF1A 471/4885FOS 63/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.